Reorientation of the SUMOylation landscape and altered L3mbtl2-mediated transcriptional activity in cancer-associated muscle contractile dysfunction
Open Access
- 9 September 2026
- journal article
- research article
- Published by Springer Nature in Cell Death Discovery
- Vol. 12 (1) , 360
Abstract
Cachexia is a debilitating muscle-wasting disorder associated with a high mortality rate in cancer patients. However, the molecular mechanisms of muscle contractile dysfunction underlying cancer-induced cachexia (CIC) remain poorly characterized. Here, we demonstrated that CIC reorients global SUMOylation in skeletal muscle cells and alters the stability of various SUMO machinery components, particularly SUMO isopeptidases. The non-canonical polycomb repressor protein L3mbtl2 was among the predominant proteins with enhanced SUMOylation level in CIC. Surprisingly, in contrast to previous notions, we found that L3mbtl2 activates transcription of a large cohort of genes regulating muscle contraction. Mechanistically, L3mbtl2 associates with Ash2L, a component of the SET1/MLL histone methyltransferase complex. Increased SUMO modification of L3mbtl2 in CIC leads to partitioning of Ash2L from its target genes, resulting in impaired calcium handling, sarcomere disorganization and impeded muscle cell contractile properties. Our findings reveal an unprecedented connection between SUMO and CIC, a paradoxical SUMO-associated transcriptional activator function of L3MBTL2 and hold potential for developing therapeutic interventions to ameliorate CIC.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (NA 1565/2-1)
- Deutsche Krebshilfe (70115510)
This publication has 55 references indexed in Scilit:
- Calcium Handling Machinery and Sarcomere Assembly are Impaired Through Multipronged Mechanisms in Cancer Cytokine‐Induced CachexiaJournal of Cachexia, Sarcopenia and Muscle, 2025
- Loss of REDD1 prevents chemotherapy‐induced muscle atrophy and weakness in miceJournal of Cachexia, Sarcopenia and Muscle, 2021
- Small‐molecule inhibition of MuRF1 attenuates skeletal muscle atrophy and dysfunction in cardiac cachexiaJournal of Cachexia, Sarcopenia and Muscle, 2017
- Genome Regulation by Polycomb and Trithorax: 70 Years and CountingCell, 2017
- Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016Journal of Cachexia, Sarcopenia and Muscle, 2016
- SUMO Signaling by Hypoxic Inactivation of SUMO-Specific IsopeptidasesCell Reports, 2016
- Molecular insights into mitochondrial dysfunction in cancer-related muscle wastingBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2014
- Modeling human cancer cachexia in colon 26 tumor‐bearing adult miceJournal of Cachexia, Sarcopenia and Muscle, 2014
- The excitation–contraction coupling mechanism in skeletal muscleBiophysical Reviews, 2014
- Cancer cachexia prevention via physical exercise: molecular mechanismsJournal of Cachexia, Sarcopenia and Muscle, 2012